Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether treatment with Belatacept (BMS-224818) is
as efficacious as treatment with cyclosporine at preventing acute rejection and with a
superior safety/tolerability profile (better kidney function and blood pressure, fewer lipid
problems, less diabetes mellitus).